Investment Summary

Athyrium Capital Management Invests In Secura Bio

On March 5, 2019, asset manager Athyrium Capital Management invested in life science company Secura Bio

Investment Highlights
  • This is Athyrium Capital Management’s 18th transaction in the Life Science sector.
  • This is Athyrium Capital Management’s 32nd transaction in the United States.
  • This is Athyrium Capital Management’s 1st transaction in Nevada.

Investment Summary

Date 2019-03-05
Target Secura Bio
Sector Life Science
Investor(s) Athyrium Capital Management
Deal Type Growth Capital

Target

Secura Bio

Las Vegas, Nevada, United States
website
Secura Bio is a commercial-stage biopharmaceutical company that offers oncology therapies for physicians and their patients. Secura Bio is based in Las Vegas, Nevada.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor
DESCRIPTION

Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York City.


DEAL STATS #
Overall 35 of 44
Sector (Life Science) 18 of 22
Type (Growth Capital) 8 of 10
State (Nevada) 1 of 1
Country (United States) 32 of 39
Year (2019) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-01 Longevity Health Plan

Palm Beach Gardens, Florida, United States

Longevity Health Plan provides institutionalized special needs plans to long-term residents of skilled nursing facilities. The plan is focused on improving its members physical, mental, and social well-being through personalized clinical care and therapies. Longevity Health Plan was founded in 2017 and is based in Palm Beach Gardens, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-16 ArisGlobal

Coral Gables, Florida, United States

ArisGlobal is a visionary technology company that’s transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. ArisGlobal’s LifeSphere drug development platform integrates cognitive computing technologies to automate the core functions of the product lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, the LifeSphere platform delivers actionable insights, boosts efficiency, ensures compliance, and lowers total cost of ownership through a multi-tenant SaaS model. ArisGlobal was founded in 1987 and is based in Coral Gables, Florida.

Buy -